A detailed history of Alecta Tjanstepension Omsesidigt transactions in Abb Vie Inc. stock. As of the latest transaction made, Alecta Tjanstepension Omsesidigt holds 1,048,600 shares of ABBV stock, worth $200 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
1,048,600
Holding current value
$200 Million
% of portfolio
0.99%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$164.99 - $203.87 $173 Million - $214 Million
1,048,600 New
1,048,600 $186 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $337B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alecta Tjanstepension Omsesidigt Portfolio

Follow Alecta Tjanstepension Omsesidigt and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alecta Tjanstepension Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Alecta Tjanstepension Omsesidigt with notifications on news.